This multicenter before-after study aimed to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.
Multicenter observational before-after study, aiming to determine the impact of infection
related to SARS-CoV-2 on the incidence of ICU-acquired colonization and infection related to
MDR bacteria.
Inclusion Criteria:
- Expected ICU stay > 48 hours
- Rectal and nasal BMR screening performed < 48 hours after admission to ICU
Exclusion Criteria:
- Patients aged < 18 years Refusal to take part in the study ICU-stay < 48 hours At
least a second rectal and nasal BMR screening was not performed prior to ICU discharge
(a posteriori exclusion criterion).
Chu Amiens Picardie
Amiens, France
Ch Bethune
Béthune, France
Grand Hopital de L'Est Francilien
Jossigny, France
CH LENS
Lens, France
Hôpital Roger Salengro, ICU, CHU Lille
Lille, France
Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)
Lyon, France
Hospices Civils de Lyon
Lyon, France
Saad Nseir, MD,PhD, Principal Investigator
University Hospital, Lille